Závěrečná zpráva ke studii Konzervativní chelatace železa jako strategie měnící přístup k léčbě Parkinsonovy nemoci FAIRPARK.

• Title in English: Clinical Trial Summary Report Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease FAIRPARK-II
• Authors: DEMLOVÁ Regina; MATYŠKOVÁ Šárka
• Year of publication: 2020
• MU Faculty or unit: Faculty of Medicine
• Web: https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003679-31/CZ

Attached files

• 2020-08-27_FAIR-PARK-II_Informace_o_ukonceni_KH_v_CR_zprava.pdf

• Description: FAIR-PARK-II EudraCT number: 2015-003679-31 Clinical Trial Termination Information provides a comprehensive overview of clinical trial (CT) information. It describes the course of KH, including a brief description, lists CT centers and their principal investigators, and provides information on CT subjects (number of patients enrolled, number of patients who completed the study, and number of patients who did not complete it). It also contains safety information and monitored efficacy parameters, measures taken during KH, and information on audits performed.

Related projects

• Český národní uzel Evropské sítě infrastruktur klinického výzkumu (CZECRIN)